Skip to main content
OpenTrials
Recruiting

NCT Number: NCT02310178

Obesity Cohort : Medical Follow-up of Severe or Morbid Obese Patients Undergoing Bariatric Surgery

The aim of this cohort is to evaluate the follow-up of morbidly obese patients treated by several types of bariatric procedures. In addition, this study could lead to the development of clinical trials on assessment of the bariatric surgery impact.

Recruiting

Interested in participating?

Request Info

Key information

Age range

15 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

CHRU - Hôpital Saint Eloi

Montpellier, 34295, France

Location status: Recruiting

Location contact

David NOCCA, PUPH

CONTACT

[email protected]

0467337731 ext. +33

About this study

The main objective is to prospectively evaluate long-term efficiency of bariatric surgery in terms of weight loss. Moreover, this cohort wants to assess the long-term effectiveness of bariatric surgery on comorbidities and quality of life, the medical and economic impact of bariatric surgery (before-after comparison using data from health insurance), estimates the incidence of mortality and morbidity of bariatric surgery and to finish describe the evolution of patients in case of new-surgery. From a methodological point of view, the Obesity cohort is a prospective cohort study, single-center, open, with aftercare performed during life of patients. The number of inclusions is to 1500 patients. After surgery , patients will be followed at least 4 visits the first year and at least 2 visits a year then. The recommendations of the french health ministry (HAS), the frequency of visits may be increased according to the patient's progress. Follow-up visits of patients after bariatric surgery will be performed by physicians or surgeons of the multidisciplinary team responsible for the care of the patient (digestive and reconstructive surgery, anesthesiology, endocrinology, medical imaging, gastroenterology, immunology and physiology) . It will be insured for life, obesity is a chronic disease and because of the risk of late complications.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Only be considered in patients operated and followed at CHU Montpellier with bariatric surgery
  • Patients treated by bariatric surgery on CHU Montpellier
  • Agreed to participate to the study by signing an informed consent
  • Eligible to health insurance

Exclusion criteria

  • Unable to follow the patient in the long term (foreign patients, surgical use ...)
  • Inability to follow in the long run

Treatment and study plan

bariatric surgery

Procedure

all of the current bariatric surgeries are allowed in this prospective cohort study

Primary outcomes

  1. Assessment of the long-term efficiency of bariatric surgery on weight loss

    Time frame: Change from intervention to 5 years

    Assessment of weight loss

Secondary outcomes

  1. Assessment of the long-term efficiency of bariatric surgery on diabetes

    Time frame: Change from intervention to 5 years

    Assessment of blood glucose, HbA1c and diabetes medications

  2. Assessment of the long-term efficiency of bariatric surgery on High Blood Pressure

    Time frame: Change from intervention to 5 years

    Assessment of Systolic Blood Pressure and blood pressure medications

  3. Assessment of the long-term efficiency of bariatric surgery on dyslipidemia

    Time frame: Change from intervention to 5 years

    Assessment of cholesterolemia and triglyceridemia and dyslipidemia medications

  4. Assessment of the long-term efficiency of bariatric surgery on rheumatism

    Time frame: Change from intervention to 5 years

    Assessment of rheumatism medications

  5. Assessment of the long-term efficiency of bariatric surgery on respiratory pathologies

    Time frame: Change from intervention to 5 years

    Assessment of respiratory pathologies medications

  6. Assessment of the long-term efficiency of bariatric surgery on sleep apnea syndrome

    Time frame: Change from intervention to 3 months

    polysomnography tests

  7. Assessment of the long-term efficiency of bariatric surgery on quality of life

    Time frame: Change from intervention to 5 years

    Assessment of quality of life questionnaires (SF36 and BAROS)

  8. Assessment of medico-economic impact of bariatric surgery

    Time frame: Change from intervention to 5 years

    Comparison of health insurance data

  9. Assessment of mortality of bariatric surgery

    Time frame: Change from intervention to 5 years

    Assessment of the date of death

Study contacts

Contact information is provided by the study sponsor or research team.

David NOCCA, PUPH

CONTACT

[email protected]

0467337731 ext. +33

Sponsors and collaborators

Lead sponsor

University Hospital, Montpellier

Other

Registry information

Acronym: BAREVAL

Important dates

Study start
2012
Primary completion
2026
Study completion
2028
First posted
Dec 8, 2014
Registry last updated
Jun 22, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.